Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs Benzinga
Category: GLP-1 News
What are the other health benefits weight-loss drugs may offer? – TODAY
What are the other health benefits weight-loss drugs may offer? TODAY
How weight-loss drugs could help treat addiction, arthritis, more – TODAY
How weight-loss drugs could help treat addiction, arthritis, more TODAY
Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. – Barron’s
Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. Barron’s
How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine
How the New Weight Loss Medications Change Our Relationship With Food Yale School of Medicine
More claimants interested in weight-loss drugs; few are covered in comp – Business Insurance
More claimants interested in weight-loss drugs; few are covered in comp Business Insurance
Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’ – The Indian Express
Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’ The Indian Express
Zealand and Roche strike $5.3bn obesity treatment deal
The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in…
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications – The Manila Times
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications The Manila Times